X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1316) 1316
Book Review (113) 113
Conference Proceeding (63) 63
Publication (40) 40
Patent (32) 32
Book Chapter (3) 3
Book / eBook (1) 1
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (478) 478
humans (455) 455
gastroenterology & hepatology (443) 443
gastroenterology and hepatology (315) 315
male (268) 268
female (261) 261
adult (247) 247
crohn's disease (192) 192
inflammatory-bowel-disease (182) 182
middle aged (173) 173
inflammatory bowel disease (149) 149
ulcerative colitis (148) 148
abridged index medicus (147) 147
crohns-disease (142) 142
infliximab (127) 127
ulcerative-colitis (113) 113
crohn disease - drug therapy (108) 108
treatment outcome (96) 96
adolescent (91) 91
aged (86) 86
risk factors (84) 84
inflammatory bowel diseases (79) 79
care and treatment (78) 78
young adult (72) 72
therapy (69) 69
organic chemistry (58) 58
severity of illness index (57) 57
analysis (54) 54
antibodies, monoclonal - therapeutic use (54) 54
gastrointestinal diseases (53) 53
crohn disease - diagnosis (52) 52
adalimumab (51) 51
immunosuppressive agents - therapeutic use (51) 51
clinical trials (50) 50
remission induction (49) 49
life sciences (46) 46
double-blind method (45) 45
ibd (45) 45
remission (45) 45
tumor necrosis factor-alpha - antagonists & inhibitors (45) 45
follow-up studies (44) 44
azathioprine (43) 43
colitis, ulcerative - drug therapy (43) 43
crohns disease (43) 43
colitis (41) 41
crohn disease - pathology (41) 41
maintenance therapy (41) 41
retrospective studies (41) 41
gastrointestinal agents - therapeutic use (40) 40
c-reactive protein (39) 39
child (39) 39
crohn disease - genetics (38) 38
inflammation (38) 38
time factors (38) 38
animals (37) 37
gastroenterology (37) 37
medical colleges (37) 37
medical research (37) 37
risk (37) 37
incidence (35) 35
inflammatory bowel diseases - drug therapy (35) 35
quality of life (35) 35
efficacy (34) 34
prospective studies (34) 34
rheumatoid-arthritis (34) 34
surgery (34) 34
anti-inflammatory agents - therapeutic use (33) 33
chemistry (33) 33
crohn disease - complications (33) 33
crohn disease - immunology (33) 33
endoscopy (33) 33
management (33) 33
intestine (32) 32
metallurgy (32) 32
patients (32) 32
research (32) 32
chemical sciences (31) 31
health aspects (31) 31
intestinal mucosa - pathology (31) 31
prognosis (31) 31
diagnosis (30) 30
medicine, experimental (30) 30
mice (30) 30
pharmacology & pharmacy (30) 30
crohn disease - surgery (29) 29
recurrence (29) 29
aged, 80 and over (28) 28
case-control studies (28) 28
drug therapy, combination (28) 28
epidemiology (28) 28
immunosuppressive agents - adverse effects (28) 28
microbiology (28) 28
peptides (28) 28
antibodies, monoclonal - adverse effects (27) 27
cancer (27) 27
colitis, ulcerative - diagnosis (27) 27
crohn disease - epidemiology (27) 27
crohn disease - therapy (27) 27
crohn’s disease (27) 27
human necessities (27) 27
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology, ISSN 0016-5085, 07/2016, Volume 151, Issue 1, pp. 212 - 213
Journal Article
Gastroenterology, ISSN 0016-5085, 07/2016, Volume 151, Issue 1, pp. 212 - 213
Journal Article
Gastroenterology, ISSN 0016-5085, 07/2016, Volume 151, Issue 1, pp. 212 - 213
Journal Article
Gastroenterology, ISSN 0016-5085, 2016, Volume 151, Issue 1, pp. 212 - 213
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 8, pp. 711 - 721
Journal Article
Gastroenterology, ISSN 0016-5085, 2014, Volume 147, Issue 3, pp. 618 - 627.e3
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 8, pp. 699 - 710
Journal Article
Gut, ISSN 0017-5749, 05/2017, Volume 66, Issue 5, pp. 839 - 851
ObjectiveVedolizumab is a gut-selective antibody to α4β7 integrin for the treatment of ulcerative colitis (UC) and Crohn's disease (CD). We report an... 
INFLAMMATORY-BOWEL-DISEASE | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | OPPORTUNISTIC INFECTIONS | FOLLOW-UP | RISK | EXPERIENCE | COHORT | INDUCTION | GASTROENTEROLOGY & HEPATOLOGY | ADVERSE EVENTS | MAINTENANCE THERAPY | Tuberculosis - epidemiology | Age Factors | Humans | Middle Aged | Male | Narcotics - therapeutic use | Clostridium Infections - epidemiology | Adrenal Cortex Hormones - therapeutic use | Incidence | Young Adult | Treatment Failure | Infusions, Intravenous - adverse effects | Gastrointestinal Agents - immunology | Adult | Female | Colitis, Ulcerative - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Risk Factors | Sepsis - epidemiology | Chemical and Drug Induced Liver Injury - epidemiology | Randomized Controlled Trials as Topic | Crohn Disease - drug therapy | Gastrointestinal Agents - therapeutic use | Gastrointestinal Agents - adverse effects | Antibodies, Monoclonal, Humanized - immunology | Antibodies, Neutralizing - blood | Leukoencephalopathy, Progressive Multifocal - epidemiology | Neoplasms - epidemiology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Drug therapy | Crohn's disease | Ulcerative colitis | Clinical trials | Infections | Malignancy | Patients | Risk factors | Crohns disease | Inflammatory bowel disease | Studies | Tuberculosis | Tumor necrosis factor | Population | Tumor necrosis factor-TNF | TNF inhibitors | Sepsis | Safety | Drug dosages | Tumors | Index Medicus | Abridged Index Medicus | 1506 | Inflammatory Bowel Disease
Journal Article
Nestle Nutrition Institute Workshop Series, ISSN 1664-2147, 2014, Volume 79, pp. 153 - 160
Inflammatory bowel diseases (IBD) are chronic progressive diseases. Current therapeutic strategies have not significantly altered the natural history of IBD.... 
Adaptive Immunity | Inflammatory Bowel Diseases - drug therapy | Intestinal Mucosa - immunology | Humans | Treatment Outcome | Intestinal Mucosa - microbiology | Immunity, Innate | Inflammatory Bowel Diseases - diet therapy | Intestinal Mucosa - drug effects
Journal Article
Gastroenterologie Clinique et Biologique, ISSN 0399-8320, 2004, Volume 28, Issue 8, pp. 703 - 707
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2011, Volume 141, Issue 4, pp. 1194 - 1201
Journal Article
Inflammatory Bowel Diseases, ISSN 1078-0998, 03/2016, Volume 22, p. S14
Journal Article
Inflammatory Bowel Diseases, ISSN 1078-0998, 03/2016, Volume 22, p. S14
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2010, Volume 362, Issue 15, pp. 1383 - 1395
Journal Article